We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Trustworthy Fibrin Sealant Gets New Delivery Syringe

By HospiMedica International staff writers
Posted on 05 Dec 2018
A next-generation, fully assembled ergonomic fibrin sealant syringe is eight times easier to push than the previous generation.

The new Baxter International (Baxter, Deerfield, IL; USA) Prima syringe, designed for the Tisseel fibrin sealant, is a two-compartment polypropylene syringe that allows surgeons to have a higher level of precision and control during surgery, thanks to an eight-fold higher pushability and a 17% faster thawing time. More...
The pre-filled double chambers contain 1, 2, or 5 ml of the sealer protein fibrinogen and a thrombin solution. When mixed during application, they form a clot at the application site. The syringe is supplied with a tip cap, two joining pieces, and four application cannulas.

The double-chamber ready-to-use syringe is connected to a joining piece and an application cannula is mounted. The common plunger ensures that equal volumes of the two sealant components are fed through the joining piece into the cannula, where they are blended and then applied. An extended length applicator is also available for applying Tisseel laparoscopically. A complete portfolio of drip and spray applicators completes the delivery range, allowing surgeons to select the right tools to address individual patient needs.

“Launching the Prima syringe illustrates our commitment to continuously advance our proven product portfolio to better meet surgeons’ needs,” said Wil Boren, president of Baxter’s advanced surgery business. “We are focused on developing hemostats and sealants that help gynecologists overcome their biggest challenges to promote healing for their patients.”

“I’ve experienced the benefits of Tisseel firsthand with my patients and it has become a product that I rely on to help stop bleeding during gynecologic surgeries,” said Kate O’Hanlan, MD, medical director at the Laparoscopic Institute for Gynecology and Oncology (Portola Valley, CA, USA). “When one of my patients suffers a bleed, I want to be able to stop it as quickly as possible. I’m excited that the new Tisseel Prima product will allow me to treat the bleeding more quickly and easily.”

Fibrin sealants are used in a wide range of surgical procedures to help reduce local bleeding. They can be applied by dripping or spraying the solution onto bleeding tissue, where they form a fibrin clot, stopping bleeding and thereby helping the wound to heal.

Related Links:
Baxter International


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Imaging Table
Stille imagiQ2
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.